Growth Metrics

Integra Lifesciences Holdings (IART) Net Income Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.19%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 62.29%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 343.24%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.38%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn -29.87%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -29.87%
Dec 31, 2025 -26.66%
Sep 30, 2025 -28.23%
Jun 30, 2025 -133.97%
Mar 31, 2025 -40.42%
Dec 31, 2024 -24.63%
Sep 30, 2024 -30.99%
Jun 30, 2024 -33.02%
Mar 31, 2024 -27.49%
Dec 31, 2023 -40.20%
Sep 30, 2023 -15.52%
Jun 30, 2023 137.16%
Mar 31, 2023 38.19%
Dec 31, 2022 51.19%
Sep 30, 2022 56.16%
Jun 30, 2022 14.63%
Mar 31, 2022 0.15%
Dec 31, 2021 21.77%
Sep 30, 2021 48.15%
Jun 30, 2021 45.54%
Mar 31, 2021 60.44%
Dec 31, 2020 27.87%
Sep 30, 2020 117.13%
Jun 30, 2020 -26.70%
Mar 31, 2020 12.81%
Jun 30, 2018 53.55%
Mar 31, 2018 74.17%
Dec 31, 2017 150.37%
Sep 30, 2017 56.96%
Jun 30, 2017 30.95%
Mar 31, 2017 42.58%
Jun 30, 2015 -41.36%
Mar 31, 2015 -35.72%
Dec 31, 2014 -39.42%
Sep 30, 2014 -58.27%
Jun 30, 2014 90.40%
Mar 31, 2014 -42.31%
Dec 31, 2013 50.17%
Sep 30, 2013 -56.60%
Jun 30, 2013 -53.54%
Mar 31, 2013 -33.81%
Dec 31, 2012 36.01%
Sep 30, 2012 -2.90%
Jun 30, 2012 -8.80%